Commit To Buy Karyopharm Therapeutics At $15, Earn 22.9% Annualized Using Options
September 19, 2018 at 11:58 AM EDT
Investors considering a purchase of Karyopharm Therapeutics Inc (KPTI) stock, but tentative about paying the going market price of $18.83/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2019 put at the $15 strike, which has a bid at the time of this writing of $1.40..